Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
批准号:
9115222
负责人:
Barry L Carter
金额:
$70.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-08 至 2018-07-31
关键词:
AddressAdherenceAdoptionAmericanAmerican Cancer SocietyAmerican Heart AssociationBehavior TherapyCancer ControlCardiovascular DiseasesCaringCessation of lifeChronicClinicClinical PharmacistsCluster randomized trialComplexControl GroupsDiabetes MellitusDiffuseEnrollmentGoalsGuideline AdherenceGuidelinesHealthHealth PlanningHealth systemHeartHome environmentInterventionIowaLDL Cholesterol LipoproteinsLeadLiteratureManaged CareMedicalMedical HistoryMeta-AnalysisModelingNational Heart, Lung, and Blood InstituteNursesOnline SystemsPatient CarePatientsPharmacistsPhysiciansPreventionPrimary Health CarePrivate PracticePublic HealthRandomizedResearchResearch DesignRisk FactorsRisk ReductionRuralScreening for cancerSelf ManagementServicesStrategic PlanningSystemTestingbaseblood pressure regulationcardiovascular risk factorcost effectivecost effectivenessdesigneffective care managementgroup interventionhealth recordimprovedinnovationmortalitymultiple chronic conditionsnovelnovel strategiespatient orientedpreventprogramsrural areaservice interventiontreatment as usual
中文摘要
描述(申请人提供):心血管疾病(CVD)每天在美国造成2200人死亡,每39秒就有一人死亡。有证据表明,通过更好的风险因素管理,这些死亡是可以预防的,然而,许多风险因素仍然无法控制。心血管疾病患者具有高度的复杂性,并往往有许多慢性病。以患者为中心的医疗之家包括自我管理、个性化健康记录和基于团队的护理,是一种改善对多种慢性病患者的护理的战略。管理保健组织发现,集中管理的心血管风险服务可以降低死亡率。目前尚不清楚包括癌症筛查在内的预防、健康和心血管风险服务(PHCVRS)是否会在缺乏临床药剂师或专门护士的私人办公室实践中实施。我们的长期目标是通过基于团队的护理来改善对有复杂病史的患者的管理。我们开创性地使用整群随机试验来评估团队护理实施情况和指南遵从性。这一应用程序的目标是进行一项多中心、整群随机研究,利用集中式PHCVRS来支持更多缺乏大型综合医疗计划的农村地区的私人医疗机构。这项研究的标题是“改善心血管风险降低以加强农村初级保健:ICARE”。我们将把爱荷华州研究网络(IRENE)中的12个初级保健办公室分层和随机分配到PHCVRS或普通护理,并招募300名受试者。我们还将在每个办公室随机选择25名患者(n=300,总共n=600),进入被动观察组,这将使我们能够确定干预措施对未暴露的患者更广泛的传播程度。我们的中心假设是,PHCVRS将显著改善对五个国家组织支持的指南优势指标的遵守。这项拟议研究的基本原理是,实施一种改进心血管疾病管理和癌症筛查的新方法将导致创新战略,使其在美国各地的卫生系统中得到更广泛的采用。我们将实现我们的目标,并用以下具体目标检验我们的中心假设:目标1:确定是否将在私人初级保健办公室实施基于网络的PHCVRS。目的2:确定PHCVRS干预是否在干预办公室蔓延。我们的方法是创新的,因为它会提出这样的问题:“PHCVRS模式能否成功实施?”以及“护理管理是否有效?”这些问题还没有在私人执业的多种慢性病患者中得到解决。这项研究设计新颖,因为它将:1)是在小型私人诊所使用整群随机设计测试该模型的最可靠的研究;2)评估效果是否可以长期维持;3)评估“被动观察组”,以确定干预是否在整个实践中扩散。
英文摘要
DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) causes 2,200 deaths in Americans every day, with one death every 39 seconds. There is evidence that these deaths can be prevented with better risk factor management, however, many risk factors remain uncontrolled. Patients with CVD have high levels of complexity and tend to have numerous chronic conditions. The Patient-Centered Medical Home including self- management, personalized health records and team-based care is a strategy to improve care for patients with multiple chronic conditions. Managed care organizations have found that a centralized cardiovascular risk service managed can reduce mortality. It is not known if a Prevention Health & Cardiovascular Risk Service (PHCVRS) including cancer screening would be implemented in private office practices that lack clinical pharmacists or specialized nurses. Our long-range goal is to improve the management of patients with complex medical histories with team-based care. We have pioneered strategies to evaluate team care implementation and guideline adherence using cluster-randomized trials. The objective of this application is to conduct a multi-center, cluster-randomized study utilizing a centralized PHCVRS to support private medical offices in more rural areas that lack large integrated health plans. This study is titled "Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care: ICARE." We will stratify and randomize 12 primary care offices in the Iowa Research Network (IRENE) to PHCVRS or usual care and enroll 300 subjects. We will also randomly select 25 patients per office (n=300, total n=600) into a passive observation group that will allow us to determine the extent to which the intervention diffuses more broadly for unexposed patients. Our central hypothesis is that the PHCVRS will significantly improve adherence to The Guideline Advantage metrics that are supported by five national organizations. The rationale for this proposed study is that implementation of a novel approach to improve management of CVD and cancer screening will lead to innovative strategies for broader adoption by health systems throughout the U.S. We will accomplish our objectives and test our central hypothesis with the following specific aims: Aim 1: To determine if a web-based PHCVRS will be implemented within private primary care offices. Aim 2: To determine if the PHCVRS intervention diffuses throughout the intervention offices. Our approach is innovative because it will ask the questions: "Will the PHCVRS model be successfully implemented?" as well as "Is care management effective?" These questions have not been addressed for patients with multiple chronic conditions in private practice. This study design is novel because it will: 1) be the most robust study to test this model using a cluster randomized design in small private practice clinics, 2) evaluate whether the effect can be sustained long-term, and 3) evaluate a "passive observation group" to determine if the intervention diffuses throughout the practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
-
批准号:10026334
-
项目类别:
-
资助金额:$67.15万
-
财政年份:2019
-
负责人:Barry L Carter
-
依托单位:
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
-
批准号:10477383
-
项目类别:
-
资助金额:$66.0万
-
财政年份:2019
-
负责人:Barry L Carter
-
依托单位:
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
-
批准号:10685296
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2019
-
负责人:Barry L Carter
-
依托单位:
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
-
批准号:10251128
-
项目类别:
-
资助金额:$66.0万
-
财政年份:2019
-
负责人:Barry L Carter
-
依托单位:
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
-
批准号:8576979
-
项目类别:
-
资助金额:$71.57万
-
财政年份:2013
-
负责人:Barry L Carter
-
依托单位:
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
-
批准号:8716808
-
项目类别:
-
资助金额:$79.32万
-
财政年份:2013
-
负责人:Barry L Carter
-
依托单位:
A collaborative model to improve BP control and minimize racial disparities-CCC
-
批准号:8435506
-
项目类别:
-
资助金额:$43.1万
-
财政年份:2009
-
负责人:Barry L Carter
-
依托单位:
A collaborative model to improve BP control and minimize racial disparities-CCC
-
批准号:7802143
-
项目类别:
-
资助金额:$114.63万
-
财政年份:2009
-
负责人:Barry L Carter
-
依托单位:
A collaborative model to improve BP control and minimize racial disparities-CCC
-
批准号:7578145
-
项目类别:
-
资助金额:$122.97万
-
财政年份:2009
-
负责人:Barry L Carter
-
依托单位:
A collaborative model to improve BP control and minimize racial disparities-CCC
-
批准号:8242762
-
项目类别:
-
资助金额:$87.36万
-
财政年份:2009
-
负责人:Barry L Carter
-
依托单位:
A collaborative model to improve BP control and minimize racial disparities-CCC
-
批准号:8067075
-
项目类别:
-
资助金额:$103.43万
-
财政年份:2009
-
负责人:Barry L Carter
-
依托单位:
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
-
批准号:7423975
-
项目类别:
-
资助金额:$68.22万
-
财政年份:2007
-
负责人:Barry L Carter
-
依托单位:
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
-
批准号:7608706
-
项目类别:
-
资助金额:$71.64万
-
财政年份:2007
-
负责人:Barry L Carter
-
依托单位:
COLLABORATIVE MANAGEMENT OF HYPERTENSION
-
批准号:7604847
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2007
-
负责人:Barry L Carter
-
依托单位:
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
-
批准号:7790703
-
项目类别:
-
资助金额:$71.27万
-
财政年份:2007
-
负责人:Barry L Carter
-
依托单位:
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
-
批准号:7251609
-
项目类别:
-
资助金额:$71.26万
-
财政年份:2007
-
负责人:Barry L Carter
-
依托单位:
COLLABORATIVE MANAGEMENT OF HYPERTENSION
-
批准号:7377061
-
项目类别:
-
资助金额:$1.99万
-
财政年份:2006
-
负责人:Barry L Carter
-
依托单位:
COLLABORATIVE MANAGEMENT OF HYPERTENSION
-
批准号:7201389
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2005
-
负责人:Barry L Carter
-
依托单位:
Improving Adherence to Blood Pressure Guidelines
-
批准号:6785356
-
项目类别:
-
资助金额:$64.34万
-
财政年份:2003
-
负责人:Barry L Carter
-
依托单位:
Collaborative Management of Hypertension
-
批准号:6899287
-
项目类别:
-
资助金额:$67.17万
-
财政年份:2003
-
负责人:Barry L Carter
-
依托单位:
海外基金